CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Option exercise Director acquired 8,750 shares (option exercise)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- S-3ASR Offering Registration Statement
- 4 Grant or award President and CEO acquired 251,034 shares (grant or award)
- 4 Grant or award Chief Legal Off. & Corp. Sec. acquired 75,345 shares (grant or award)
- 4 Grant or award Chief Financial & Bus. Officer acquired 82,715 shares (grant or award)
- 4 Option exercise Director acquired 8,750 shares (option exercise)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 230 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Off. & Corp. Sec. gave up 7,703 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 31,502 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 48,375 shares (to pay taxes)
- 4 Open-market sale Principal Accounting Officer sold 524 shares at $13.51 ($7,079)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 3 of 25 · 496 filings